Neurofibromatosis, type 1 (von Recklinghausen's disease)
Also known as: NF 1 / NF1 / Neurofibromatosis Type 1 (NF1) / Neurofibromatosis 1 (NF1) / Neurofibromatosis Type 1 / Neurofibromatosis Type I / Von Recklinghausen Disease / Neurofibromatosis 1 / Neurofibromatosis I / Neurofibromatosis, type 1 / Neurofibromatosis type 1 (disorder) / Von Recklinghausen's disease (of nerve) / Neurofibromatosis, unspecified / Neurofibromatoses / Neurofibromatosis / Neurofibromatosis (morphologic abnormality) / Neurofibromatosis syndrome (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB11689 | Selumetinib | A MEK 1/2 inhibitor used in pediatric patients to treat neurofibromatosis type 1 (NF1) accompanied by symptomatic, inoperable plexiform neurofibromas (PN). |